| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 16428 | 2012 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 10136 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 8985 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 6734 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 5930 | 2015 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … II Abubakar, T Tillmann, A Banerjee Lancet 385 (9963), 117-171, 2015 | 4850 | 2015 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 4781 | 2018 |
| International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study AS Buist, MA McBurnie, WM Vollmer, S Gillespie, P Burney, DM Mannino, ... The Lancet 370 (9589), 741-750, 2007 | 3130 | 2007 |
| How can airborne transmission of COVID-19 indoors be minimised? L Morawska, JW Tang, W Bahnfleth, PM Bluyssen, A Boerstra, ... Environment international 142, 105832, 2020 | 1110 | 2020 |
| A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis MR Elkins, M Robinson, BR Rose, C Harbour, CP Moriarty, GB Marks, ... New England Journal of Medicine 354 (3), 229-240, 2006 | 985 | 2006 |
| After asthma: redefining airways diseases ID Pavord, R Beasley, A Agusti, GP Anderson, E Bel, G Brusselle, ... The Lancet 391 (10118), 350-400, 2018 | 820 | 2018 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990 … GBD 2013 Risk Factors Collaborators Lancet (London, England) 386 (10010), 2287, 2015 | 779* | 2015 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 759 | 2017 |
| Contact investigation for tuberculosis: a systematic review and meta-analysis GJ Fox, SE Barry, WJ Britton, GB Marks European Respiratory Journal 41 (1), 140-156, 2013 | 706 | 2013 |
| Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries H Getahun, A Matteelli, I Abubakar, MA Aziz, A Baddeley, D Barreira, ... European Respiratory Journal 46 (6), 1563-1576, 2015 | 614 | 2015 |
| Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial CL Phillips, RR Grunstein, MA Darendeliler, AS Mihailidou, VK Srinivasan, ... American journal of respiratory and critical care medicine 187 (8), 879-887, 2013 | 535 | 2013 |
| Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial PG Gibson, IA Yang, JW Upham, PN Reynolds, S Hodge, AL James, ... The Lancet 390 (10095), 659-668, 2017 | 530 | 2017 |
| A scale for the measurement of quality of life in adults with asthma GB Marks, SM Dunn, AJ Woolcock Journal of clinical epidemiology 45 (5), 461-472, 1992 | 488 | 1992 |
| Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis JS Ried, J Li, XB Zuo, XD Zheng, XY Yin, LD Sun, MA McAleer, ... Nature genetics 47 (12), 1449-1456, 2015 | 475 | 2015 |
| Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization G D’Amato, ST Holgate, R Pawankar, DK Ledford, L Cecchi, M Al-Ahmad, ... World Allergy Organization Journal 8 (1), 1-52, 2015 | 460 | 2015 |
Brett ToelleWoolcock Institute of Medical ResearchVerified email at sydney.edu.au
